Eruptive lentiginosis in resolving plaque psoriasis associated with methotrexate therapy

1. Micieli R, Alavi A. Eruptive lentiginosis in resolving psoriatic plaques. JAAD Case Reports. 2018;4:924-929. [PMID: 29693059].

2. Larosa CL, Foulke GT, Feigenbaum DF, Cordoro KM, Zaenglein AL. Lentigines in resolving psoriatic plaques: Rarely reported sequelae in pediatric cases. Pediatr Dermatol. 2015;32:e114-e117. [PMID: 25727728].

3. Souto FG. Eruptive lentiginosis confined to areas of regressing psoriatic plaques after adalimumab treatment. An Bras Dermatol. 2021;96:113-114. [PMID: 33272688].

4. Palmisano G, Di Stefani A, Cappilli S, Chiricozzi A, Peris K. Eruptive lentiginosis in resolving plaque psoriasis during treatment with risankizumab. Ski Res Technol. 2023;29:2-3. [PMID: 37881038].

5. María PS, Valenzuela F, Morales C, De la Fuente R, Cullen R. Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: A case report and review of the literature. Dermatology Reports. 2017;9:43-45. [PMID: 29090075].

6. Lee EB, Reynolds KA, Pithadia DJ, Wu JJ. Appearance of lentigines in psoriasis patient treated with guselkumab. Dermatol Online J. 2019;25. [PMID: 30710906].

7. Singh S, Beniwal R. Methotrexate-induced eruptive lentiginosis in resolving psoriasis: A phenomenon possibly dependent on cytokine modulation. Clin Exp Dermatol. 2019;44:e212-e213. [PMID: 30900774].

8. Braun J. Methotrexate: Optimizing the efficacy in rheumatoid arthritis. Ther Adv Musculoskelet Dis. 2011;3:151-158. [PMID: 22870474].